Go to deals
Food & Beverage | Healthcare

Harmonium International Inc. has sold a minority stake to Lallemand

Laboratories Stand has sold a minority sake in Harmonium International Inc. to Lallemand for US$30 million.

Lallemand is a global leader in the development, production and marketing of yeast, bacteria and specialty ingredients.

Laboratoires Standa develops and commercializes products which maintain the original quality of food products (ATCO and SANICO ranges) and brings under control the fermentation of dairy products.

Oaklins' team in Montreal, Canada, acted as the exclusive advisor to the seller in this transaction.

Parties

Talk to the deal team

Sebastien Nadeau

Managing Partner
Montreal, Canada
Oaklins Canada

Related deals

The Providence Projects has been acquired by UKAT Group
Private Equity | Healthcare

The Providence Projects has been acquired by UKAT Group

Celebrity-success rehabilitation center, The Providence Projects, has joined The UK Addiction Treatment (UKAT) Group, backed by Sullivan Street Equity Partners.

Learn more
St. Claraspital AG has been acquired by University Hospital Basel
Healthcare

St. Claraspital AG has been acquired by University Hospital Basel

University Hospital Basel (USB) has acquired St. Claraspital AG, expanding its network of specialized care and integrated services. With St. Claraspital’s strong community presence, expertise in acute and rehabilitation medicine and established outpatient clinics, this merger enhances USB’s ability to provide seamless, patient-centered treatment across the continuum of care. The completion of the transaction is subject to clearance by the Swiss Competition Commission (COMCO).

Learn more
RAM Infotechnology has acquired Interoperability Group with support from Keensight Capital
Private Equity | Healthcare | TMT

RAM Infotechnology has acquired Interoperability Group with support from Keensight Capital

RAM Infotechnology (RAM-IT) has acquired Interoperability Group, a leading Dutch provider of healthcare IT solutions, with the support of Keensight Capital, a leading European growth buy-out investor specializing in technology and healthcare.

Learn more